Related Experiment Video

Updated: Aug 22, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

[Hypothyroid dilated cardiomyopathy]

L Bezdah1, H Slimène, M Kammoun

  • 1Service de cardiologie, hôpital Charles-Nicolle, boulevard du 9 Avril, 1006 Tunis, Tunisie. famsli@planet.tn

Annales De Cardiologie Et D'Angeiologie
|September 17, 2004
PubMed

Insights

Severe hypothyroidism can cause dilated cardiomyopathy and heart failure, which is reversible with thyroid hormone replacement therapy. This case highlights the importance of considering hypothyroidism in patients diagnosed with dilated cardiomyopathy.

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Dilated cardiomyopathy often presents with poor prognosis due to irreversible myocardial dysfunction.
  • Metabolic causes for dilated cardiomyopathy are rare but can be responsive to specific treatments.
  • The link between hypothyroidism and myocardial dysfunction is known, but its role in causing dilated cardiomyopathy remains debated.

Observation:

  • A patient presented with severe hypothyroidism and dilated cardiomyopathy complicated by heart failure.
  • The patient's cardiac function improved significantly after treatment with L-thyroxine, restoring euthyroid state.

Findings:

  • Severe hypothyroidism can be a direct cause of dilated cardiomyopathy and heart failure.
  • Thyroid hormone replacement therapy can reverse myocardial dysfunction in hypothyroid patients with dilated cardiomyopathy.

Implications:

  • Hypothyroidism should be systematically investigated in patients diagnosed with dilated cardiomyopathy.
  • Early diagnosis and treatment of hypothyroidism may prevent irreversible cardiac damage.
  • This case supports the inclusion of metabolic screening, specifically thyroid function, in the workup of unexplained heart failure.

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...